This study aimed to establish rapidly detecting the expression of survivin antigens for cancer vaccines or molecular targeted therapies via flow cytometry (FCM) using the intracellular staining method in tumor samples obtained via needle biopsy without anesthesia. Here, BIRC5 is linked to neoplasm.